Sarcomed
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Keywords | CMC, Regulatory Affairs, Drug Repurposing, Cdmo, Orphan Drug Development, Fda/Ema |
| Founded | 2014 |
| Employees | 1-10 |
Key Contact at Sarcomed
Filmon Solomon
CEO & Founder
Sarcomed Email Formats
Sarcomed uses 1 email format. The most common is {first name} (e.g., john@sarcomed.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@sarcomed.com | 100% |
About Sarcomed
About Us Sarcomed AB is a biotech company focused on developing treatments for rare muscular dystrophies, holding 14 FDA orphan drug designations. We specialize in advancing repurposed compounds to accelerate patient access to innovative therapies for rare neuromuscular diseases. Products & Services Beyond drug development, Sarcomed provides regulatory consulting services to support biotech companies in navigating complex approval pathways. Our services include: - Orphan Drug Designation (ODD) applications for FDA and EMA - Pre-IND meeting preparation and strategy - Biomarker validation support - CDMO business development freelance services With expertise in regulatory strategy and rare disease drug development, we help bring promising therapies closer to patients in need.
Sarcomed revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Sarcomed has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Sarcomed has never raised funding before.
United States
Spain
United Kingdom
Frequently asked questions
4.8
40,000 users
